Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Appointment Dr Robert Skalla topic
No spam. Unsubscribe anytime.
House Health Committee hears confirmation testimony from Dr. Robert Skalla for Alaska State Medical Board
Summary
Dr. Robert Skalla told the House Health and Social Services Committee about 20 years of Alaska practice, his work on diabetes care and plans to prioritize access and fair licensing; members questioned him on telemedicine, pharmaceutical influence and board training. No committee vote was taken.
Dr. Robert Skalla, a board-certified family medicine physician practicing in Eagle River, told the House Health and Social Services Committee on May 5 that he was appointed last week to the Alaska State Medical Board and is already reviewing board minutes and onboarding materials.
Skalla summarized his qualifications, including a DO from the Chicago College of Osteopathic Medicine, residency at Doctors Hospital in Columbus, Ohio, U.S. Army medical service and two decades of private practice in Alaska focused on diabetes and lipid disorders. He said his clinic was the first in Alaska to receive a National Committee for Quality Assurance recognition for diabetes care and that he established the state's first dedicated outpatient diabetes and cholesterol clinic in 2005.
"I've seen the medical board's role in licensing competent providers, and reviewing complaints fairly, and setting a standard that helps us to protect patients and support access, especially in rural and remote areas," Skalla said.
Committee members pressed Skalla on several issues. Representative Gray asked about Skalla's outside projects, including an AI-assisted 'saint choosing' application; Skalla described the tool as a questionnaire-based matching program that pairs users to patron-saint biographies. Gray also raised concerns from her experience about pharmaceutical representatives influencing prescribing; Skalla acknowledged that an earlier era of heavy rep presence had been curtailed by regulation but cautioned the committee to preserve scientific exchange and disease-state education.
Representative Schwanke focused questioning on rural health delivery. Skalla said many patients travel long distances for specialty care — "I've already seen one patient who drove six hours to come and see me" — and recommended telemedicine, expanded use of physician assistants and nurse practitioners with regional physician backup, and careful use of AI to increase clinical capacity.
Skalla said he has begun required onboarding training and will attend the next Alaska State Medical Board meeting to review pending cases. Chair Representative Mina closed the testimony by thanking Skalla; the committee did not vote during the hearing, and the committee report will be signed later per statute.
The committee noted the hearing was conducted in accordance with AS 39.5.80; no public testimony was offered on Skalla’s appointment during the public-comment period. The committee adjourned at 3:57 p.m.
